News for Alithya Group Inc. (ALYA.TO)

PR NewswireMONTREAL, Feb. 27, 2025 MONTREAL, Feb. 27, 2025 /PRNewswire/ - Alithya's President and Chief Executive Officer, Paul Raymond, will speak at the

PR NewswireMONTREAL, Feb. 17, 2025 MONTREAL, Feb. 17, 2025 /PRNewswire/ - Alithya Group inc. (TSX: ALYA) ("Alithya") announced today that CRN®, a brand of

Alithya Group Inc. (OTCPK:ALYAF) Q3 2025 Results Conference Call February 13, 2025 9:00 AM ETCompany ParticipantsBenjamin Cerantola - Director of...

PR NewswireMONTREAL, Feb. 13, 2025 Q3-2025 HighlightsRevenues decreased 3.9% to $115.8 million, compared to $120.5 million for the same quarter last year.

Alithya Group Inc (TSX:ALYA) is set to release its Q3 2025 earnings on Feb 13, 2025. The consensus estimate for Q3 2025 revenue is $113.38 million, and the earn

PR NewswireMONTREAL, Dec. 2, 2024 MONTREAL, Dec. 2, 2024 /PRNewswire/ - Alithya Group inc. (TSX: ALYA) ("Alithya") is pleased to announce the acquisition o

Alithya acquires XRM Vision, deepening Microsoft expertise and strengthening smart shore capabilities

Strategic cost management & diversification into high-value services have helped Alithya (ALYA:CA) maintain margins. See why I continue to rate the stock a buy.

Adjusted EBITDA: Increased by 11.1% to above $10 million.Gross Margin: Increased to 31.9% from 28.9% year-over-year.Net Cash Flow from Operating Activities: $1

Aug 14, 2024 / 01:00PM GMTOperator Good morning. Welcome to Alithya's First Quarter Fiscal 2025 Results Conference Call. I will now like to turn the meeting ove

Alithya Group Inc. (OTCPK:ALYAF) Q1 2025 Results Conference Call August 14, 2024 9:00 AM ETCompany ParticipantsPaul Raymond - President and Chief Executive...

Jun 13, 2024 / 01:00PM GMTOperator Good morning, and welcome to Alithya's fourth quarter and fiscal 2024 results conference call. I would now like to turn the m

Alithya reports continued performance improvement with record Gross Margin as a Percentage of Revenues and Adjusted EBITDA

Alithya Group Inc. (OTC:ALYAF) Q4 2024 Earnings Conference Call June 13, 2024 9:00 AM ETCompany ParticipantsPaul Raymond - President, CEO &...

Alithya has shown operational resilience by defying margin erosion. Click here to see why ALYAF stock is a Buy.

MicroAlgo Inc. (MLGO) is up over 49% in Thursday's pre-market trading. The following are some of the stocks making big moves..

MicroAlgo Inc. (MLGO) is up over 49% in Thursday's pre-market trading. The following are some of the stocks making big moves..

Biora Therapeutics, Inc. (BIOR) has gained more than 55% in Friday's pre-market trading. The following are some of the other stocks making big moves..

Shares of SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) surged in pre-market trading after the company reported the FDA approval of OGSIVEO (nirogacestat) as the first and only treatment for adults with desmoid tumors. SpringWorks Therapeutics shares rose 14.4% to $23.77 in pre-market trading